Cargando…

Clinical Course of Dual-Chamber Implantable Cardioverter-Defibrillator Recipients followed by Cardiac Remote Monitoring: Insights from the LION Registry

Patients receiving dual-chamber implantable cardioverter-defibrillator (DR-ICD) therapy are at risk of developing atrial arrhythmia because of the increased rate of ventricular pacing and the progression of heart failure. Remote monitoring (RM) may identify the patients at highest risk of adverse ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwab, Joerg O., Nägele, Herbert, Oswald, Hanno, Klein, Gunnar, Gunkel, Oliver, Lang, Andreas, Bauer, Wolfgang R., Korb, Paul, Hauser, Tino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241353/ https://www.ncbi.nlm.nih.gov/pubmed/30519574 http://dx.doi.org/10.1155/2018/3120480

Ejemplares similares

Home monitoring of implantable cardioverter-defibrillators: interpretation reliability of the second-generation “IEGM Online” system
por: Nägele, Herbert, et al.
Publicado: (2015)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

Experience with a Wearable Cardioverter-defibrillator in 436 Patients
por: Nägele, Herbert, et al.
Publicado: (2022)

Predictors of early mortality in implantable cardioverter-defibrillator recipients
por: Stein, Kenneth M., et al.
Publicado: (2009)

Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring()
por: Galand, Vincent, et al.
Publicado: (2021)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Chronic Kidney Disease and Mortality in Implantable Cardioverter-Defibrillator Recipients
por: Cheema, Aamir, et al.
Publicado: (2010)

Arrhythmic triad in an implantable cardioverter‐defibrillator recipient with severe hypokalemia
por: Ciriello, Giovanni Domenico, et al.
Publicado: (2022)

Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators
por: Burri, Haran, et al.
Publicado: (2009)

The Gulf Implantable Cardioverter-defibrillator Registry: Rationale, Methodology, and Implementation
por: Alsheikh-Ali, Alawi A., et al.
Publicado: (2015)

Performance of a multisensory implantable cardioverter-defibrillator algorithm for remote heart failure management: the RE-HEART registry
por: De Juan Baguda, J, et al.
Publicado: (2021)

Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
por: Borne, Ryan T., et al.
Publicado: (2021)

Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators
por: Bagherzadeh, Ataallah, et al.
Publicado: (2006)

Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
por: Zormpas, Christos, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

Outcomes of single- or dual-chamber implantable cardioverter defibrillator systems in Japanese patients
por: Ueda, Akiko, et al.
Publicado: (2016)

Dual‐chamber implantable cardioverter–defibrillator. Is it useful in patient with permanent atrial fibrillation?
por: Porres‐Aracama, José M., et al.
Publicado: (2016)

Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial
por: Hindricks, Gerhard, et al.
Publicado: (2014)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

Radiofrequency remote monitor software patch update without cybersecurity implantable cardioverter-defibrillator firmware update increases the risk of inappropriate implantable cardioverter-defibrillator therapies
por: Qian, Xiaoxiao, et al.
Publicado: (2022)

Accelerometer-assessed physical behavior and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: A systematic review
por: Kolk, Maarten Z.H., et al.
Publicado: (2021)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial
por: Bänsch, Dietmar, et al.
Publicado: (2015)

Recurrent shocks in a dual chamber implantable cardioverter defibrillator: Making sense of the chaos
por: Yeo, Colin, et al.
Publicado: (2018)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Single-chamber Versus Dual-chamber Implantable Cardioverter Defibrillators: Do We Need Physiologic Pacing in The Course?
por: Budeus, Marco, et al.
Publicado: (2006)

Predictors of Mortality Amongst Recipients of Implantable Cardioverter Defibrillators for Secondary Prevention of Cardiac Arrest
por: Agarwal, Sunil K, et al.
Publicado: (2007)

Long-term survival of implantable cardioverter defibrillator recipients with end-stage renal disease
por: El-Chami, Mikhael F., et al.
Publicado: (2017)

Sex difference in inappropriate therapy and survival among 1471 implantable cardioverter‐defibrillator recipients
por: Burger, Achim Leo, et al.
Publicado: (2019)

Diffuse myocardial fibrosis associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients
por: Olausson, Eric, et al.
Publicado: (2023)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

The economic impact of remote control in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators: single center experience
por: Marini, M, et al.
Publicado: (2023)

Contributions of remote monitoring to the follow-up of implantable cardioverter–defibrillator leads under advisory
por: Guédon-Moreau, Laurence, et al.
Publicado: (2010)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Gulf Implantable Cardioverter-defibrillator Registry Reflects Advanced Cardiac Care in the Arab Gulf
por: Albinali, Hajar A.
Publicado: (2015)

Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
por: Kempa, Maciej, et al.
Publicado: (2021)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1rsrs01fhfisno1iojgj7fvtjj